WB analysis of rat spinal cord lysate using GTX89301 CILP antibody, Internal. Dilution : 0.03microg/ml Loading : 35microg protein in RIPA buffer
WB analysis of rat spinal cord lysate using GTX89301 CILP antibody, Internal. Dilution : 0.03microg/ml Loading : 35microg protein in RIPA buffer
CILP antibody, Internal
GTX89301
Overview
- SupplierGeneTex
- Product NameCILP antibody, Internal
- Delivery Days Customer7
- Application Supplier NoteWB: 0.1-0.3microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.50 mg/ml
- ConjugateUnconjugated
- Gene ID8483
- Target nameCILP
- Target descriptioncartilage intermediate layer protein
- Target synonymscartilage intermediate layer protein 1; cartilage intermediate layer protein 1 C1; cartilage intermediate layer protein 1 C2; cartilage intermediate layer protein, nucleotide pyrophosphohydrolase; CILP-1; HsT18872
- HostGoat
- IsotypeIgG
- Protein IDO75339
- Protein NameCartilage intermediate layer protein 1
- Scientific DescriptionMajor alterations in the composition of the cartilage extracellular matrix occur in joint disease, such as osteoarthrosis. This gene encodes the cartilage intermediate layer protein (CILP), which increases in early osteoarthrosis cartilage. The encoded protein was thought to encode a protein precursor for two different proteins; an N-terminal CILP and a C-terminal homolog of NTPPHase, however, later studies identified no nucleotide pyrophosphatase phosphodiesterase (NPP) activity. The full-length and the N-terminal domain of this protein was shown to function as an IGF-1 antagonist. An allelic variant of this gene has been associated with lumbar disc disease. [provided by RefSeq, Sep 2010]
- ReactivityRat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203